²Ü¹úÓ¢
Guoying Cao
¸´µ©´óѧ¸½Êô»ªÉ½Ò½ÔºÒ©ÎïÁÙ´²ÊÔÑé»ú¹¹°ì¹«ÊÒÖ÷ÈΡ¢ÁÙ´²Ò©ÀíÑо¿ÖÐÐÄÖ÷ÒªÑо¿Õߣ¨PI£©
Director of Clinical Trial Office and the Principal Investigator of Clinical Pharmacology Research Center, Huashan Hospital affiliated to Fudan University
²Ü¹úÓ¢ÓÚ2002Äê»ñµÃÁÙ´²Ò½Ñ§Ñ§Ê¿Ñ§Î»£¬2010Äê»ñµÃ¸´µ©´óѧÉϺ£Ò½Ñ§ÔºÄÚ¿Æѧ£¨´«È¾²¡£©Ë¶Ê¿Ñ§Î»¡£ËýÔÚ»ªÉ½Ò½Ôº¹¤×÷³¬¹ý20Ä꣬Ö÷Òª¸ºÔð´´ÐÂÒ©ÎïºÍÒ½ÁÆÆ÷еµÄÁÙ´²ÊÔÑé¹ÜÀí£»ËýÒ²ÊÇ»ªÉ½Ò½ÔºÁÙ´²Ò©ÀíÑо¿ÖÐÐÄIÆÚÁÙ´²ÊÔÑéµÄÖ÷ÒªÑо¿ÕßÖ®Ò»¡£ÔÚÕâЩÄêÀËýÒÑÍê³É³¬¹ý100ÏîIÆÚÁÙ´²ÊÔÑ飬°üÀ¨9Ïî×÷ΪPIµÄÁÙ´²ÊÔÑé¡£
Guoying Cao acquired her Bachelor degree of Clinical Medicine in 2002, and Master degree of Internal Medicine (Infectious Diseases) in 2010, from Shanghai Medical College of Fudan University. She has been working in Huashan Hospital for more than 20 years, mainly responsible for management of clinical trials of innovative drug and medical device. She is also one of the principal investigators for Phase I clinical trials in clinical pharmacology research center in Huashan Hospital. She has finished more than 100 Phase I clinical trials during these years, including 9 clinical trials as PI.
Guoying Cao
¸´µ©´óѧ¸½Êô»ªÉ½Ò½ÔºÒ©ÎïÁÙ´²ÊÔÑé»ú¹¹°ì¹«ÊÒÖ÷ÈΡ¢ÁÙ´²Ò©ÀíÑо¿ÖÐÐÄÖ÷ÒªÑо¿Õߣ¨PI£©
Director of Clinical Trial Office and the Principal Investigator of Clinical Pharmacology Research Center, Huashan Hospital affiliated to Fudan University
²Ü¹úÓ¢ÓÚ2002Äê»ñµÃÁÙ´²Ò½Ñ§Ñ§Ê¿Ñ§Î»£¬2010Äê»ñµÃ¸´µ©´óѧÉϺ£Ò½Ñ§ÔºÄÚ¿Æѧ£¨´«È¾²¡£©Ë¶Ê¿Ñ§Î»¡£ËýÔÚ»ªÉ½Ò½Ôº¹¤×÷³¬¹ý20Ä꣬Ö÷Òª¸ºÔð´´ÐÂÒ©ÎïºÍÒ½ÁÆÆ÷еµÄÁÙ´²ÊÔÑé¹ÜÀí£»ËýÒ²ÊÇ»ªÉ½Ò½ÔºÁÙ´²Ò©ÀíÑо¿ÖÐÐÄIÆÚÁÙ´²ÊÔÑéµÄÖ÷ÒªÑо¿ÕßÖ®Ò»¡£ÔÚÕâЩÄêÀËýÒÑÍê³É³¬¹ý100ÏîIÆÚÁÙ´²ÊÔÑ飬°üÀ¨9Ïî×÷ΪPIµÄÁÙ´²ÊÔÑé¡£
Guoying Cao acquired her Bachelor degree of Clinical Medicine in 2002, and Master degree of Internal Medicine (Infectious Diseases) in 2010, from Shanghai Medical College of Fudan University. She has been working in Huashan Hospital for more than 20 years, mainly responsible for management of clinical trials of innovative drug and medical device. She is also one of the principal investigators for Phase I clinical trials in clinical pharmacology research center in Huashan Hospital. She has finished more than 100 Phase I clinical trials during these years, including 9 clinical trials as PI.
